EUVIMEDEUVIMED entdecken
Crossref

Epigenetic markers for sensory phenotypes of type 2 diabetes polyneuropathy

Meriem Ouni, Klara Kemnitz, Amandeep Singh, Zoltán Kender, Elisabeth Kliemank, Markus Jähnert, Dimitrios Tsilinigiris, Stefan Kopf, Julia Szendrödi, Annette Schürmann, Alba Sulaj

Diabetologie und Stoffwechsel · 01.04.2024 · 19 (S 01 S 01) · S11

DOI: 10.1055/s-0044-1785250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologie und Stoffwechsel, erschienen am 01.04.2024. Verfasst von Meriem Ouni und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Growing evidence links epigenetic alterations to the progression of diabetes and its complications. However, it remains unclear whether these epigenetic changes can be used as (bio)markers for the development of type 2 diabetes (T2D) complications. Thus, we aimed to identify epigenetic markers for the development of T2D polyneuropathy.

Method

T2D patients included in the present study are a subgroup of the Heidelberg study on diabetes and complications. Quantitative sensory testing was applied to distinguish between different sensory phenotypes: 16 with no symptoms, 53 with sensory gain (thermal and mechanical hyperalgesia), and 29 with sensory loss. DNA methylation profiling was assessed in blood cells of the three groups, followed by bioinformatic analyses. Differentially methylated sites were calculated by pairwise comparison and corrected for multiple testing (Benjamini-Hochberg method).

Results

Since sensory gain appears to be an intermediate stage in the progression of severe T2D polyneuropathy, DNA methylation profiled in both stages were examined. Compared to participants without neuropathy, people with sensory gain had more than 4500 altered methylation sites in blood cells while individuals with sensory loss had 700 (FDR

Zitieren

APA

Ouni, M., Kemnitz, K., Singh, A., Kender, Z., Kliemank, E., Jähnert, M., Tsilinigiris, D., Kopf, S., Szendrödi, J., Schürmann, A., & Sulaj, A. (2024). Epigenetic markers for sensory phenotypes of type 2 diabetes polyneuropathy. Diabetologie und Stoffwechsel, 19(S 01 S 01), S11. https://doi.org/10.1055/s-0044-1785250

Vancouver

Ouni M, Kemnitz K, Singh A, Kender Z, Kliemank E, Jähnert M, et al. Epigenetic markers for sensory phenotypes of type 2 diabetes polyneuropathy. Diabetologie und Stoffwechsel. 2024;19(S 01 S 01):S11. doi:10.1055/s-0044-1785250

BibTeX
@article{Ouni2024,
  author = {Ouni, Meriem and Kemnitz, Klara and Singh, Amandeep and Kender, Zoltán and Kliemank, Elisabeth and Jähnert, Markus and Tsilinigiris, Dimitrios and Kopf, Stefan and Szendrödi, Julia and Schürmann, Annette and Sulaj, Alba},
  title = {Epigenetic markers for sensory phenotypes of type 2 diabetes polyneuropathy},
  journal = {Diabetologie und Stoffwechsel},
  year = {2024},
  volume = {19},
  number = {S 01 S 01},
  pages = {S11},
  doi = {10.1055/s-0044-1785250}
}
Kostenlos starten →